Carboxyl-terminated PAMAM-SN38 conjugates: Synthesis, characterization, and in vitro evaluation

Bioconjugate Chemistry

Volumn 21, Issue 10, 2010, Pages 1804-1810

  Vijayalakshmi, Nirmalkumar ^a,c   Ray, Abhijit ^a,c   Malugin, Alexander ^a,c   Ghandehari, Hamidreza ^a,b,c  

^a UNIVERSITY OF UTAH   (United States)

^b University of Utah   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; BETA ALANINE; GLYCINE; POLYAMIDOAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL STRAIN HCT116; CELL VIABILITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; FRAGMENTATION REACTION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; NONHUMAN; PH; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

RATTUS;

EID: 77958156329     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100094z     Document Type: Article

References (29)

1. Duncan, R. (2006) Polymer conjugates as anticancer nanomedicines Nat. Rev. Cancer 6, 688-701
2. Li, C. and Wallace, S. (2008) Polymer-drug conjugates: recent development in clinical oncology Adv. Drug Delivery Rev. 60, 886-98
3. Majoros, I. J., Williams, C. R., and Baker, J. R., Jr. (2008) Current dendrimer applications in cancer diagnosis and therapy Curr. Top. Med. Chem. 8, 1165-79
4. Duncan, R. and Izzo, L. (2005) Dendrimer biocompatibility and toxicity Adv. Drug Delivery Rev. 57, 2215-37
5. Pommier, Y. (2009) DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition Chem. Rev. 109, 2894-902
6. Ulukan, H. and Swaan, P. W. (2002) Camptothecins: a review of their chemotherapeutic potential Drugs 62, 2039-57
7. Shimada, Y., Rothenberg, M., Hilsenbeck, S. G., Burris, H. A., 3rd, Degen, D., and Von Hoff, D. D. (1994) Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming units Anticancer Drugs 5, 202-6
8. Ulukan, H., Muller, M. T., and Swaan, P. W. (2001) Downregulation of topoisomerase I in differentiating human intestinal epithelial cells Int. J. Cancer 94, 200-7
9. Smith, N. F., Figg, W. D., and Sparreboom, A. (2006) Pharmacogenetics of irinotecan metabolism and transport: an update Toxicol. In Vitro 20, 163-75
10. Caiolfa, V. R., Zamai, M., Fiorino, A., Frigerio, E., Pellizzoni, C., d'Argy, R., Ghiglieri, A., Castelli, M. G., Farao, M., Pesenti, E., Gigli, M., Angelucci, F., and Suarato, A. (2000) Polymer-bound camptothecin: initial biodistribution and antitumour activity studies J. Controlled Release 65, 105-19
11. Zhao, H., Rubio, B., Sapra, P., Wu, D., Reddy, P., Sai, P., Martinez, A., Gao, Y., Lozanguiez, Y., Longley, C., Greenberger, L. M., and Horak, I. D. (2008) Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers Bioconjugate Chem. 19, 849-59
12. Moon, S. J., Govindan, S. V., Cardillo, T. M., D'Souza, C. A., Hansen, H. J., and Goldenberg, D. M. (2008) Antibody conjugates of 7-ethyl-10- hydroxycamptothecin (SN-38) for targeted cancer chemotherapy J. Med. Chem. 51, 6916-26
13. Kolhatkar, R. B., Swaan, P., and Ghandehari, H. (2008) Potential oral delivery of 7-ethyl-10-hydroxy-camptothecin (SN-38) using poly(amidoamine) dendrimers Pharm. Res. 25, 1723-9
14. Patri, A. K., Kukowska-Latallo, J. F., and Baker, J. R., Jr. (2005) Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex Adv. Drug Delivery Rev. 57, 2203-14
15. Kolhatkar, R. B., Kitchens, K. M., Swaan, P. W., and Ghandehari, H. (2007) Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability Bioconjugate Chem. 18, 2054-60
16. Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W., and Ghandehari, H. (2007) Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells Pharm. Res. 24, 2138-45
17. Shapiro, H. M. (1988) pp 353, Alan R. Liss Inc, NewYork.
18. Singer, J. W., De Vries, P., Bhatt, R., Tulinsky, J., Klein, P., Li, C., Milas, L., Lewis, R. A., and Wallace, S. (2000) Conjugation of camptothecins to poly-(L-glutamic acid) Ann. N. Y. Acad. Sci. 922, 136-50
19. Bhatt, R., de Vries, P., Tulinsky, J., Bellamy, G., Baker, B., Singer, J. W., and Klein, P. (2003) Synthesis and in vivo antitumor activity of poly(l-glutamic acid) conjugates of 20S-camptothecin J. Med. Chem. 46, 190-3
20. Fox, M. E., Guillaudeu, S., Frechet, J. M., Jerger, K., Macaraeg, N., and Szoka, F. C. (2009) Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates Mol. Pharm. 6, 1562-72
21. Chen, X., McRae, S., Parelkar, S., and Emrick, T. (2009) Polymeric phosphorylcholine-camptothecin conjugates prepared by controlled free radical polymerization and click chemistry Bioconjugate Chem. 20, 2331-41
22. Najlah, M., Freeman, S., Attwood, D., and D'Emanuele, A. (2006) Synthesis, characterization and stability of dendrimer prodrugs Int. J. Pharm. 308, 175-82
23. Ishikawa, T., Otsuki, M., and Iwatsuki, T. (1986) Enzymatic esterolysis of polymers containing 2-biphenylyl ester bonds in side chains Bull. Chem. Soc. Jpn. 59, 3621-3624
24. Vicent, M. J., Greco, F., Nicholson, R. I., Paul, A., Griffiths, P. C., and Duncan, R. (2005) Polymer therapeutics designed for a combination therapy of hormone-dependent cancer Angew. Chem., Int. Ed. Engl. 44, 4061-6
25. Khandare, J. J., Jayant, S., Singh, A., Chandna, P., Wang, Y., Vorsa, N., and Minko, T. (2006) Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel Bioconjugate Chem. 17, 1464-72
26. Perumal, O., Khandare, J., Kolhe, P., Kannan, S., Lieh-Lai, M., and Kannan, R. M. (2009) Effects of branching architecture and linker on the activity of hyperbranched polymer-drug conjugates Bioconjugate Chem. 20, 842-846
27. Tsao, Y. P., D'Arpa, P., and Liu, L. F. (1992) The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B Cancer Res. 52, 1823-9
28. Ueno, M., Nonaka, S., Yamazaki, R., Deguchi, N., and Murai, M. (2002) SN-38 induces cell cycle arrest and apoptosis in human testicular cancer Eur. Urol. 42, 390-7
29. Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., and Kroemer, G. (2007) Cell death modalities: classification and pathophysiological implications Cell Death Differ. 14, 1237-43